These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25591141)

  • 1. Pulmonary hypertension in idiopathic pulmonary fibrosis does not influence six-minute walk distance: results from a retrospective study.
    Harari S; Caminati A; Cassandro R; Conti S; Madotto F; Luisi F; Cesana G
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):297-305. PubMed ID: 25591141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
    Modrykamien AM; Gudavalli R; McCarthy K; Parambil J
    Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis.
    Minai OA; Santacruz JF; Alster JM; Budev MM; McCarthy K
    Respir Med; 2012 Nov; 106(11):1613-21. PubMed ID: 22902266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.
    du Bois RM; Weycker D; Albera C; Bradford WZ; Costabel U; Kartashov A; Lancaster L; Noble PW; Sahn SA; Szwarcberg J; Thomeer M; Valeyre D; King TE
    Am J Respir Crit Care Med; 2011 May; 183(9):1231-7. PubMed ID: 21131468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
    Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y
    Respiration; 2013; 85(6):456-63. PubMed ID: 23257350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study.
    Kim MJ; Nathan SD; Kim HH; Kim HC
    Ther Adv Respir Dis; 2024; 18():17534666241275329. PubMed ID: 39175212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right Ventricular Structure and Function in Idiopathic Pulmonary Fibrosis with or without Pulmonary Hypertension.
    D'Andrea A; Stanziola A; Di Palma E; Martino M; D'Alto M; Dellegrottaglie S; Cocchia R; Riegler L; Betancourt Cordido MV; Lanza M; Maglione M; Diana V; Calabrò R; Russo MG; Vannan M; Bossone E
    Echocardiography; 2016 Jan; 33(1):57-65. PubMed ID: 26096076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associated Pulmonary Hypertension Is an Independent Contributor to Exercise Intolerance in Chronic Fibrosing Interstitial Pneumonias.
    Yoo DK; Zompatori M; Barrile A; Rossi G; D'Amato D; Sergiacomi G; Rogliani P; Mura M
    Respiration; 2018; 96(6):543-551. PubMed ID: 30114688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis.
    Nathan SD; du Bois RM; Albera C; Bradford WZ; Costabel U; Kartashov A; Noble PW; Sahn SA; Valeyre D; Weycker D; King TE
    Respir Med; 2015 Jul; 109(7):914-22. PubMed ID: 25956020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.
    Boutou AK; Pitsiou GG; Trigonis I; Papakosta D; Kontou PK; Chavouzis N; Nakou C; Argyropoulou P; Wasserman K; Stanopoulos I
    Respirology; 2011 Apr; 16(3):451-8. PubMed ID: 21122030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen saturation recovery after 6-minute walk test in patients with idiopathic pulmonary fibrosis.
    Oğuz MS; Bingöl Z; Pıhtılı A; Karaca Özer P; Sarıtaş Arslan M; Kılıçaslan Z; Bilge AK; Kıyan E; Okumuş G
    BMC Pulm Med; 2024 Jul; 24(1):373. PubMed ID: 39085811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.
    Pitsiou G; Papakosta D; Bouros D
    Respiration; 2011; 82(3):294-304. PubMed ID: 21677422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
    Mirsaeidi M; Omar HR; Baughman R; Machado R; Sweiss N
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):317-320. PubMed ID: 28079843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.
    Corte TJ; Wort SJ; Wells AU
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):7-19. PubMed ID: 19960783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.
    Alkukhun L; Wang XF; Ahmed MK; Baumgartner M; Budev MM; Dweik RA; Tonelli AR
    Respir Med; 2016 Aug; 117():65-72. PubMed ID: 27492515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.
    Kim KH; Maldonado F; Ryu JH; Eiken PW; Hartman TE; Bartholmai BJ; Decker PA; Yi ES
    Respir Res; 2010 Apr; 11(1):37. PubMed ID: 20398288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference.
    Swigris JJ; Wamboldt FS; Behr J; du Bois RM; King TE; Raghu G; Brown KK
    Thorax; 2010 Feb; 65(2):173-7. PubMed ID: 19996335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis.
    Swigris JJ; Olson AL; Shlobin OA; Ahmad S; Brown KK; Nathan SD
    Respirology; 2011 Apr; 16(3):439-45. PubMed ID: 20946337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.